Biologic agents used to treat rheumatoid arthritis and their relevance to podiatrists: a practice update.
This review considers the pharmacological management of rheumatoid arthritis including the role of anti-tumour necrosis factor alpha (TNFalpha) agents, as a precursor to highlighting some of the issues for podiatrists involved in the care of patients on this particular medication.
Otter
S J
SJ
School of Health Professions, University of Brighton. so54@bton.ac.uk
Young
A
A
Cryer
J R
JR